Solriamfetol may be an effective alternative for managing ADHD in adults, trial shows

Ar­bu­tus plans to lay off 40% of its staff af­ter end­ing one of three on­go­ing mid­stage he­pati­tis B tri­als. The de­ci­sion to cut the study

A type 1 diabetes patient talked about her successful treatment with an investigational stem cell therapy currently in trials, noting that she hasn’t needed insulin